Skip to main content
. 2019 Nov 29;12:10427–10439. doi: 10.2147/OTT.S229231

Figure 1.

Figure 1

Expression levels of CCT6A mRNA and its association with survival rates in patients with liver cance. (A) Transcription levels of CCT6A in HCC tissues from the ONCOMINE database. (B) mRNA expression of CCT6A in HCC tissues in TCGA samples from the UALCAN database. (C) Transcription levels of CCT6A associated with HCC patients’ individual grades and stages based on the UALCAN database. (D) Correlation of CCT6A mRNA expression with overall survival (OS; n = 182, p = 0.0063) and disease-free survival (DFS; n = 182, p = 0.026) from the GEPIA database. *p < 0.05, **p < 0.01, ***p < 0.001.